ADETOKUNBO ADEREMI-IBITOLA: Open Payments
NPI 1932749553 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,748 in 166 payments from 19 companies in 2025. Trend: 2023 $2,405 · 2024 $4,484 · 2025 $4,748
Food & beverage: $4,671Education: $73Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $831 |
| ABBVIE INC. | 31 | $464 |
| Regeneron Healthcare Solutions, Inc. | 6 | $453 |
| Lilly USA, LLC | 12 | $412 |
| LEO Pharma Inc. | 4 | $319 |
| Incyte Corporation | 18 | $318 |
| PFIZER INC. | 12 | $285 |
| Galderma Laboratories, L.P. | 13 | $248 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 11 | $243 |
| Novartis Pharmaceuticals Corporation | 5 | $212 |
Products named: TREMFYA, DUPIXENT, OPZELURA, SKYRIZI, EBGLYSS, NEMLUVIO, Zoryve, CIBINQO.
Industry payments across VA — which companies pay providers there.
